Inactief instrument

Andere talen Shilpa Medicare Ltd NSE India S.E.

Aandelen

INE790G01023

slotkoers NSE India S.E. Andere beurzen
- ^INR	-

24/05	Transcript : Shilpa Medicare Limited, Q4 2024 Earnings Call, May 24, 2024
23/05	Shilpa Medicare Limited rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Transcript : Shilpa Medicare Limited, Q4 2024 Earnings Call, May 24, 2024	24/05
Shilpa Medicare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	23/05
Shilpa Medicare Limited Announces Successful Completion of Early Clinical Development and Ongoing Phase 3 Clinical Trial of Its Newly Developed Drug "SML-007", for the Treatment of Non-Alalcoholic Fatty Liver Disease	14/05
Shilpa Medicare Gets Board Nod to Launch QIP	09/04
Shilpa Medicare's Life Science Arm Names CEO	28/03
Shilpa Medicare's New Unit in Hyderabad, India Gets Zero Observations from US FDA	01/03
Shilpa Medicare Gets Approval to Market Smoking Cessation Drug in Europe	26/02
Transcript : Shilpa Medicare Limited, Q3 2024 Earnings Call, Feb 12, 2024	12/02
Shilpa Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Shilpa Medicare Gets Germany's Marketing Approval for Rare Muscles Diseases Drug	19/01
Shilpa Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10/11
Shilpa Medicare Acquires US-Based Pilnova Pharma	03/11
Shilpa Medicare Limited Launches Naturally Derived Option for the Treatment of Oral Mucositis in India Under the Brand Name Oraal	11-10-23
Shilpa Medicare Unit's API Manufacturing Plant Gets Clearance from Japanese Drug Regulator's Inspection	04-09-23
Shilpa Medicare Gets UK Drug Regulator's Nod to Market Drug for Meniere's Syndrome Symptoms	04-09-23
Shilpa Medicare Limited Receives Marketing Authorization from MHRA, UK, for Betahistine Dihydrochloride Orodispersible Films, 24 mg	01-09-23
Shilpa Medicare's Manufacturing Facility in Telangana Gets Clearance from Brazilian Regulator	25-08-23
Transcript : Shilpa Medicare Limited, Q1 2024 Earnings Call, Aug 11, 2023	11-08-23
Shilpa Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10-08-23
Shilpa Medicare Gets Regulatory Nod for Pemetrexed Injections	01-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shilpa Medicare Ltd NSE India S.E.

Aandelen

INE790G01023

Andere talen

Filters